Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Quoin Pharmaceuticals Ltd DRC
QNRXCurrent price
0.58 USD
-0.0075 USD (-1.29%)
Last closed
0.56 USD
Company
quoinpharma.com
ISIN
US74907L1026
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 393 156 USD
Yield for 12 month
-88.94 %
1Y
3Y
5Y
10Y
15Y
QNRX
Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. operates as a subsidiary of Skinvisible, Inc. Address: 42127 Pleasant Forest Court, Ashburn, VA, United States, 20148-7349
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-103 438 USD
Last Year
-103 635 USD
Current Quarter
-24 908 USD
Last Quarter
-25 277 USD
Key Figures QNRX
1 year
3 years
5 years
10 years
EBITDA
-8 836 608 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-36.32 %
PEG Ratio
–
Return On Equity TTM
-100.03 %
Wall Street Target Price
4.67 USD
Revenue TTM
–
Book Value
1.88 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-5.05 USD
Diluted Eps TTM
-5.05 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics QNRX
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History QNRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
18.07.2023
Dividend Date
23.10.2019
Stock Valuation QNRX
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.4219
Price Book MRQ
0.32
Financials QNRX
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators QNRX
For 52 weeks
0.48 USD
5.75 USD
50 Day MA
0.61 USD
Shares Short Prior Month
2 623
200 Day MA
1.78 USD
Short Ratio
0.22
Shares Short
12 316
Short Percent
0.31 %
BeatStart